Source link : https://www.newshealth.biz/health-news/pancreatic-gene-therapy-a-one-and-done-glp-1-treatment/
TOPLINE: An experimental pancreatic gene therapy given to a mouse model of obesity as a one-time, single-dose treatment showed improvements in body composition and fasting glucose comparable with those achieved with the glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide, without the reversal of fat-loss and glycemia improvements that are a key concern with the withdrawal […]
Author : News Health
Publish date : 2024-06-25 11:14:17
Copyright for syndicated content belongs to the linked Source.
Categories